LuRa: Efficacy and Safety of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
Jabra Zarka(Mayo Clinic), Daniel S. Childs(Mayo Clinic in Arizona), MD Ayse Tuba Kendi(Mayo Clinic), Irbaz B Riaz(Mayo Clinic in Arizona), Adam M. Kase(Jacksonville College), Yael Kusne(WinnMed), Matthew Thorpe(University of Edinburgh), Miguel Muniz(Mayo Clinic in Arizona), Gokce Belge Bilgin, Zachary Scharf(Mayo Clinic in Arizona), Arsalan Naqvi(Mayo Clinic in Arizona), Geoffrey B. Johnson(Mayo Clinic), Ali Tarhini(Mayo Clinic in Arizona), Oliver Sartor(East Jefferson General Hospital), Ronit Juthani(Dana-Farber Cancer Institute), Eugene D. Kwon(Mayo Clinic in Arizona), Mrinal S. Patnaik(Mayo Clinic in Arizona), Elisabeth Heath(Mayo Clinic in Arizona), Heather Jacene(Dana-Farber Cancer Institute), Jacob J. Orme(Mayo Clinic), Praful Ravi(Dana-Farber Cancer Institute), Albert Jang(University Hospitals Seidman Cancer Center)
Cited by 0
Related Papers
Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE ε4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene
|Journal of Alzheimer s Disease|2010|155
Bi- and uniciliated ependymal cells define continuous floor-plate-derived tanycytic territories
|Nature Communications|2017|115
Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models
|Brain Research|2010|107
Spectrum of clonal hematopoiesis in VEXAS syndrome
|Blood|2023|106
Visual system manifestations of Alzheimer's disease
|Acta Ophthalmologica|2016|75